Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayoshi Suzuki

Showing results (1-10 of 424) with videos related to

Pageof 43
Sort By:
Chemical & Pharmaceutical Bulletin|September 2, 2009
Explorative study on isoform-selective histone deacetylase inhibitorsTakayoshi Suzuki
Chemical & Pharmaceutical Bulletin|January 31, 2024
ForewordTakayoshi Suzuki
Chemical Record (New York, N.Y.)|December 15, 2018
Special Issue: (Bio)Chemical Aspects of EpigeneticsTakayoshi Suzuki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2017
"Drug" Discovery with the Help of Organic ChemistryYukihiro Itoh, Takayoshi Suzuki
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|December 20, 2024
Four functional genotoxic marker genes (Bax, Btg2, Ccng1, and Cdkn1a) discriminate genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens and non-genotoxic non-hepatocarcinogens in rat public toxicogenomics data, Open TG-GATEsChie Furihata, Takayoshi Suzuki
Current Medicinal Chemistry|November 25, 2005
Non-hydroxamate histone deacetylase inhibitorsTakayoshi Suzuki, Naoki Miyata
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Bis[μ-2-(aminosulfanyl)pyridine(1-)]bis-[(η-penta-methyl-cyclo-penta-dien-yl)iridium(III)] diiodideYusuke Sekioka, Takayoshi Suzuki
Chemical Record (New York, N.Y.)|October 3, 2018
Drug Design Concepts for LSD1-Selective InhibitorsYosuke Ota, Takayoshi Suzuki
Journal of Medicinal Chemistry|January 2, 2025
G9a/GLP Modulators: Inhibitors to DegradersAnirban Mukherjee, Takayoshi Suzuki
Journal of Medicinal Chemistry|June 1, 2021
Synthetic RNA Modulators in Drug DiscoveryFarzad Zamani, Takayoshi Suzuki
Pageof 43

Showing results (1-10 of 424) with videos related to

Sort By:
Pageof 43
Chemical & Pharmaceutical Bulletin|September 2, 2009
Explorative study on isoform-selective histone deacetylase inhibitorsTakayoshi Suzuki
Chemical & Pharmaceutical Bulletin|January 31, 2024
ForewordTakayoshi Suzuki
Chemical Record (New York, N.Y.)|December 15, 2018
Special Issue: (Bio)Chemical Aspects of EpigeneticsTakayoshi Suzuki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2017
"Drug" Discovery with the Help of Organic ChemistryYukihiro Itoh, Takayoshi Suzuki
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|December 20, 2024
Four functional genotoxic marker genes (Bax, Btg2, Ccng1, and Cdkn1a) discriminate genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens and non-genotoxic non-hepatocarcinogens in rat public toxicogenomics data, Open TG-GATEsChie Furihata, Takayoshi Suzuki
Current Medicinal Chemistry|November 25, 2005
Non-hydroxamate histone deacetylase inhibitorsTakayoshi Suzuki, Naoki Miyata
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Bis[μ-2-(aminosulfanyl)pyridine(1-)]bis-[(η-penta-methyl-cyclo-penta-dien-yl)iridium(III)] diiodideYusuke Sekioka, Takayoshi Suzuki
Chemical Record (New York, N.Y.)|October 3, 2018
Drug Design Concepts for LSD1-Selective InhibitorsYosuke Ota, Takayoshi Suzuki
Journal of Medicinal Chemistry|January 2, 2025
G9a/GLP Modulators: Inhibitors to DegradersAnirban Mukherjee, Takayoshi Suzuki
Journal of Medicinal Chemistry|June 1, 2021
Synthetic RNA Modulators in Drug DiscoveryFarzad Zamani, Takayoshi Suzuki
Pageof 43